Martin L Sos

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 9

Top Venues

Nature communications

Oncogene

Cancer research

NPJ precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Nina Müller, Carina Lorenz, Jenny Ostendorp, Felix S Heisel, Ulrich P Friese, Maria Cartolano, Dennis Plenker, Hannah L Tumbrink, Alena Heimsoeth, Philipp Baedeker, Sandra Ortiz-Cuaran, Jonathan Weiss, Reinhard Buttner, Martin Peifer, Roman K Thomas, Martin L Sos, Johannes Berg, Johannes Brägelmann
Characterizing evolutionary dynamics reveals strategies to exhaust the spectrum of subclonal resistance in EGFR-mutant lung cancer. Cancer research (2023)
Lisa Werr, Dennis Plenker, Marcel A Dammert, Carina Lorenz, Johannes Brägelmann, Hannah L Tumbrink, Sebastian Klein, Anna Schmitt, Reinhard Büttner, Thorsten Persigehl, Kevan M Shokat, F Thomas Wunderlich, Alison M Schram, Martin Peifer, Martin L Sos, Hans Christian Reinhardt, Roman K Thomas
CD74-NRG1 Fusions Are Oncogenic In Vivo and Induce Therapeutically Tractable ERBB2:ERBB3 Heterodimerization. Molecular cancer therapeutics 21 (5) (2022)
Christopher A French, Michael L Cheng, Glenn J Hanna, Steven G DuBois, Nicole G Chau, Christine L Hann, Simone Storck, Ravi Salgia, Matteo Trucco, Jennifer Tseng, Anastasios Stathis, Richard L Piekarz, Ulrich M Lauer, Christophe Massard, Kelly Bennett, Shodeinde Coker, Ulrike Tontsch-Grunt, Martin L Sos, Sida Liao, Catherine J Wu, Kornelia Polyak, Sarina A Piha-Paul, Geoffrey I Shapiro
Report of the First International Symposium on NUT Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (12) (2022)
Johannes Brägelmann, Carina Lorenz, Sven Borchmann, Kazuya Nishii, Julia Wegner, Lydia Meder, Jenny Ostendorp, David F Ast, Alena Heimsoeth, Takamasa Nakasuka, Atsuko Hirabae, Sachi Okawa, Marcel A Dammert, Dennis Plenker, Sebastian Klein, Philipp Lohneis, Jianing Gu, Laura K Godfrey, Jan Forster, Marija Trajkovic-Arsic, Thomas Zillinger, Mareike Haarmann, Alexander Quaas, Stefanie Lennartz, Marcel Schmiel, Joshua D'Rozario, Emily S Thomas, Qi-Xiang Li, Clemens A Schmitt, Julie George, Roman K Thomas, Silvia von Karstedt, Gunther Hartmann, Reinhard Buttner, Roland T Ullrich, Jens Thomas Siveke, Kadoaki Ohashi, Martin Schlee, Martin L Sos
MAPK-pathway inhibition mediates inflammatory reprogramming and sensitizes tumors to targeted activation of innate immunity sensor RIG-I. Nature communications 12 (1) (2021)
Christina M Bebber, Emily S Thomas, Jenny Stroh, Zhiyi Chen, Ariadne Androulidaki, Anna Schmitt, Michaela N Höhne, Lukas Stüker, Cleidson de Pádua Alves, Armin Khonsari, Marcel A Dammert, Fatma Parmaksiz, Hannah L Tumbrink, Filippo Beleggia, Martin L Sos, Jan Riemer, Julie George, Susanne Brodesser, Roman K Thomas, H Christian Reinhardt, Silvia von Karstedt
Ferroptosis response segregates small cell lung cancer (SCLC) neuroendocrine subtypes. Nature communications 12 (1) (2021)
Diana Schaufler, David F Ast, Hannah L Tumbrink, Nima Abedpour, Lukas Maas, Ayla E Schwäbe, Inga Spille, Stefanie Lennartz, Jana Fassunke, Mihaela Aldea, Benjamin Besse, David Planchard, Lucia Nogova, Sebastian Michels, Carsten Kobe, Thorsten Persigehl, Theresa Westphal, Sophia Koleczko, Rieke Fischer, Jan-Phillip Weber, Janine Altmüller, Roman K Thomas, Sabine Merkelbach-Bruse, Oliver Gautschi, Laura Mezquita, Reinhard Buttner, Jürgen Wolf, Martin Peifer, Johannes Brägelmann, Matthias Scheffler, Martin L Sos
Clonal dynamics of BRAF-driven drug resistance in EGFR-mutant lung cancer. NPJ precision oncology 5 (1) (2021)
Lucia Nogova, Christian Mattonet, Matthias Scheffler, Max Taubert, Masyar Gardizi, Martin L Sos, Sebastian Michels, Rieke N Fischer, Meike Limburg, Diana S Y Abdulla, Thorsten Persigehl, Carsten Kobe, Sabine Merkelbach-Bruse, Jeremy Franklin, Heiko Backes, Roland Schnell, Dirk Behringer, Britta Kaminsky, Martina Eichstaedt, Christoph Stelzer, Martina Kinzig, Fritz Sörgel, Yingying Tian, Lisa Junge, Ahmed A Suleiman, Sebastian Frechen, Dennis Rokitta, Dongsheng Ouyang, Uwe Fuhr, Reinhard Buettner, Jürgen Wolf
Sorafenib and everolimus in patients with advanced solid tumors and KRAS-mutated NSCLC: A phase I trial with early pharmacodynamic FDG-PET assessment. Cancer medicine 9 (14) (2020)
Hannah L Tumbrink, Alena Heimsoeth, Martin L Sos
The next tier of EGFR resistance mutations in lung cancer. Oncogene 40 (1) (2020)
Dennis Plenker, Maximilian Riedel, Johannes Brägelmann, Marcel A Dammert, Rakhee Chauhan, Phillip P Knowles, Carina Lorenz, Marina Keul, Mike Bührmann, Oliver Pagel, Verena Tischler, Andreas H Scheel, Daniel Schütte, Yanrui Song, Justina Stark, Florian Mrugalla, Yannic Alber, André Richters, Julian Engel, Frauke Leenders, Johannes M Heuckmann, Jürgen Wolf, Joachim Diebold, Georg Pall, Martin Peifer, Maarten Aerts, Kris Gevaert, René P Zahedi, Reinhard Buettner, Kevan M Shokat, Neil Q McDonald, Stefan M Kast, Oliver Gautschi, Roman K Thomas, Martin L Sos
Drugging the catalytically inactive state of RET kinase in RET-rearranged tumors. Science translational medicine 9 (394) (2018)

Martin L Sos.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Martin L Sos